Combining exhaled-breath data and clinical variables can adequately distinguish lung cancer patients. »
05/04/22

Distinct mechanisms between primary and acquired resistance revealed. »
05/03/22

Frequency of reversion mutations higher in patients with objective (58%) or prostate-specific antigen response. »
03/11/22

Highlighting physical association of Fusobacterium with colorectal cancer. »
03/25/22

GS subtype tumors have potential to possess distinct signatures. »
08/10/22

Age at diagnosis decisive factor predicting disease-specific mortality. »
08/02/22

Previously hidden molecular program promotes medulloblastoma formation. »
10/18/22

17 FRGs strongly associated with patient survival. »
10/23/22

Enhanced effects on cellular proliferation and regrowth observed with combination therapy. »
10/29/22

Normal BHK-21 cells recorded undetectable IC50 values. »
10/29/22